Add Row
Add Element
cropper
update
PractitionersOfHealth - a CapidHouser.com media site
update
Add Element
  • Home
  • Categories
    • dentistry
    • cosmetics
    • opticians
    • physiotherapy
    • chiropractor
    • osteopathy
  • Massage Therapy
  • Yoga Therapy
  • diet and nutrition
  • reflexology
June 28.2025
2 Minutes Read

Aesthetic Procedure Demand Steadily Grows Amid Economic Uncertainty

Young woman consulting with the best cosmetic surgeon in a soft-lit clinic.


Demand for Aesthetic Procedures Remains Resilient in 2024

In a year marked by economic unpredictability, the cosmetic surgery industry has demonstrated remarkable stability. According to the recent report from the American Society of Plastic Surgeons (ASPS), both surgical and non-surgical aesthetic procedures saw continued growth in 2024. This trend is especially notable as it reflects a broader cultural commitment to personal well-being and enhancement, underscoring the importance individuals place on how they present themselves to the world.

Highlighting the Most Popular Cosmetic Procedures

The report revealed nearly 1.6 million cosmetic surgeries performed in 2024, with liposuction leading the list at 349,728 procedures, followed closely by breast augmentations and tummy tucks. These figures indicate that individuals are prioritizing body confidence, even amid financial challenges. Additionally, the popularity of minimally invasive treatments, such as neuromodulator injections and hyaluronic acid fillers, supports the idea that quick recovery options are appealing to a busy populace.

The Role of Surgical Expertise in Weight Loss

Interestingly, the 2024 report also introduced data on weight loss medications prescribed by ASPS member surgeons, showcasing an evolving role for plastic surgeons beyond cosmetic enhancements. Over 800,000 aesthetic patients engaged in weight loss support, indicating a significant intersection between aesthetic and health goals. For 20% of patients on GLP-1 medications, prior plastic surgery had already occurred, while 39% expressed interest in surgical procedures.

Understanding Patient Priorities Amid Economic Challenges

As individuals navigate economic uncertainties, their desire to maintain or improve their aesthetic health remains a priority. ASPS President Scott Hollenbeck, MD, emphasizes that despite safety concerns during these tumultuous times, patients are eager to explore aesthetic options that enhance both their appearance and confidence. This preference shines a light on the vital relationship between self-perception and emotional well-being.

A Call to Action: Trust the Experts

For anyone considering cosmetic procedures, understanding the landscape of surgical options and prioritizing safety is paramount. Consult ASPS member surgeons to ensure you receive the highest standard of care. Remember, choosing the right expert can significantly impact your journey toward aesthetic fulfillment.


cosmetics

2 Views

0 Comments

Write A Comment

*
*
Related Posts All Posts
07.04.2025

FDA Extends Opzelura Review: Hope for Pediatric Atopic Dermatitis Treatment

Update FDA’s Extended Review: Implications for Pediatric Atopic Dermatitis TreatmentThe recent announcement by Incyte regarding the FDA’s extension of the review period for Opzelura, a topical treatment for atopic dermatitis in children aged 2-11, has significant implications for young patients and their families. For many parents, the frustration of watching their child struggle with a chronic skin condition can be overwhelming. This extension, now pushing the Prescription Drug User Fee Act action date to September 19, 2025, means there’s still hope for new treatment avenues amidst increasing numbers of children diagnosed with atopic dermatitis.Understanding Atopic DermatitisAtopic dermatitis is more than just skin deep; it's linked to immune system responses, and managing its symptoms can be challenging. Millions of children in the U.S. deal with this condition, leading to potential sleepless nights and discomfort. Steven Stein, MD, the chief medical officer at Incyte, emphasizes the importance of innovative treatments like ruxolitinib cream, which could offer relief without the steroids typically prescribed for such conditions.Positive Results from Clinical TrialsThe optimism surrounding Opzelura stems from its Phase 3 TRuE-AD3 study, which showcased significant treatment success compared to vehicle (non-medicated) controls. In the study, higher rates of treatment efficacy were recorded, which is essential information for parents seeking effective solutions for their children’s condition. Potential new remedies that minimize reliance on steroids could pave the way for enhanced treatment options.Addressing Safety ConcernsWhen it comes to any new treatment, the safety profile is paramount. Opzelura demonstrated no new safety signals during the trial, and it did not lead to severe adverse events. Learning that the most common side effect—application site pain—was mild and transient offers reassurance to parents exploring treatment options for their young ones.Why Parents Should Stay InformedAs a parent, staying informed about new treatments like Opzelura can be invaluable. Understanding available options, such as which pediatric plastic surgery specialists are trusted for related conditions or how to navigate cosmetic approaches, can empower parents to make informed health decisions for their children. As the FDA continues to evaluate Opzelura's application, the hope is that it will lead to new, safe, and effective treatments for pediatric atopic dermatitis, reducing the hardship many families face daily.

07.04.2025

Opzelura Review Extension: What It Means For Kids with Atopic Dermatitis

Update New Hope for Kids Struggling with Atopic DermatitisThe recent announcement from Incyte regarding their topical treatment, Opzelura, brings a ray of hope for children aged 2 to 11 suffering from atopic dermatitis. This chronic and uncomfortable skin condition affects millions of children in the United States, making effective treatments highly sought after. With the FDA extending the review period to September 19, 2025, more time will be devoted to scrutinizing the chemistry and manufacturing of this promising new drug.Understanding the Importance of OpzeluraCurrent treatments for atopic dermatitis primarily include topical steroids, which can have side effects, especially in young patients. The potential availability of Opzelura as a non-steroidal topical treatment could significantly improve the quality of life for many families. This move towards a less invasive treatment option aligns with broader health trends favoring approaches with fewer complications.What Parents Should Know About Atopic DermatitisAtopic dermatitis can be challenging not only for the child but also for parents who witness their child suffering. Dr. Steven Stein, the Chief Medical Officer at Incyte, emphasizes the vital need for effective non-steroidal treatments. Given Opzelura’s positive results from the TRuE-AD3 study, this cream shows promise, achieving significant treatment success and demonstrating an overall safe profile.Examining the Efficacy of OpzeluraThe Phase 3 study revealed compelling outcomes: children treated with Opzelura had a noticeable improvement in their condition compared to those using a non-medicated cream. In particular, over 75% of patients demonstrated significant improvements in their eczema severity within just eight weeks. Such rapid results can alleviate worry for parents seeking effective solutions.The Future of Pediatric Dermatological TreatmentsThe extended review period also indicates a commitment to ensuring that the drug, once approved, meets the highest standards for safety and efficacy. As families look for trustworthy options for their children’s skin conditions, this could guide parents in their search for the best cosmetic and dermatological care. The anticipation surrounding Opzelura signals a shift in how we might approach not just atopic dermatitis treatment, but also other pediatric skin conditions in the future.As the future unfolds, parents and caregivers are encouraged to stay informed and involved as the FDA navigates its review process. Keeping an eye on upcoming developments can empower families to ask the right questions and pursue the best treatment avenues for their children.

07.04.2025

FDA Delays Decision on Opzelura: What Parents Should Know About Pediatric Atopic Dermatitis

Update The FDA's Deliberation: What It Means for Children's Health The U.S. Food and Drug Administration (FDA) has extended its review period for the supplemental New Drug Application (sNDA) of Opzelura, a topical cream by Incyte intended for treating mild to moderate atopic dermatitis in children aged 2 to 11. This extension, moving the action date to September 19, 2025, allows the FDA crucial time to review additional data concerning the product's manufacturing and controls. Understanding Atopic Dermatitis in Children Atopic dermatitis is a chronic skin condition that affects millions of children across the U.S., often leading to discomfort and distress. Dr. Steven Stein, Incyte’s chief medical officer, emphasizes the necessity for innovative treatment options that do not rely on steroids, which are commonly prescribed but can have side effects. With the global incidence of atopic dermatitis rising, the potential approval of Opzelura could offer an alternative therapeutic strategy for families coping with this condition. Positive Signs from Clinical Trials The green light for Opzelura came after promising results from the phase 3 TRuE-AD3 clinical trial. This study illustrated that significantly more children receiving Opzelura achieved notable improvements in their skin conditions compared to those using a non-medicated control cream. Among the specific measures, 75% demonstrated substantial improvement in the Eczema Area and Severity Index after eight weeks of treatment. The Journey Ahead for Families and Healthcare Providers As families eagerly await FDA's final decision, the extended review period provides a moment of reflection. This protracted timeline urges parents to consider the broader implications of children's health and the importance of reliable, effective treatments that ground themselves in safety and efficacy. As we anticipate the upcoming decision, it also highlights a vital reality: the transformative effect that a new treatment option can have on the lives of children and their families. For parents searching for the best practices to manage their child's health, staying informed about advancements like Opzelura is crucial. If you have a child suffering from atopic dermatitis, consider discussing these developments with your healthcare provider, as they can provide insights tailored to your child’s specific health needs.

Add Row
Add Element
cropper
update
PractitionersOfHealth
cropper
update

Write a small description of your business and the core features and benefits of your products.

  • update
  • update
  • update
  • update
  • update
  • update
  • update
Add Element

COMPANY

  • Privacy Policy
  • Terms of Use
  • Advertise
  • Contact Us
  • Menu 5
  • Menu 6
Add Element

+447974613172

AVAILABLE FROM 8AM - 5PM

City, State

, ,

Add Element

ABOUT US

Write a small description of your business and the core features and benefits of your products.

Add Element

© 2025 CompanyName All Rights Reserved. Address . Contact Us . Terms of Service . Privacy Policy

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*